Rimegepant: all 45 studies that test it

Page 1 of 1. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.

• Rimegepant Plus Toripalimab in Advanced Urothelial Carcinoma After Failure of Standard TherapyRecruitingNCT07835035Phase 1
• Rimegepant-Sensitized Neoadjuvant Chemoimmunotherapy for Oral or Oropharyngeal Squamous Cell CarcinomaNot yet recruitingNCT07812467Phase 2
• Rimegepant For Endometriosis PainNot yet recruitingNCT07795125Phase 2
• A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Prevention: Rimegepant Versus Flunarizine Non-inferiority StudyNot yet recruitingNCT07751497Phase 2
• A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic MigraineRecruitingNCT07729462Phase 3
• A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in IndiaRecruitingNCT07685769Phase 4
• A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency DepartmentNot yet recruitingNCT07667621Phase 1
• Rimegepant Plus Glofitamab and CD19 CAR-T Therapy in R/R LBCLNot yet recruitingNCT07613788Phase 2
• A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With MigraineRecruitingNCT07609914Phase 4
• Rimegepant Combined With AG Chemotherapy As First-Line Treatment For Metastatic Pancreatic Ductal AdenocarcinomaNot yet recruitingNCT07475234Phase 1/2
• Efficacy and Safety of Rimegepant for Acute DizzinessNot yet recruitingNCT07435090Phase 2/3
• Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the USRecruitingNCT07301008Phase 4
• Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer PatientsNot yet recruitingNCT06999252Phase 2
• A Clinical Trial of Rimegepant for Vestibular Migraine Evaluation: Pre-experimentNot yet recruitingNCT06748664Phase 2
• A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual MigraineRecruitingNCT06641466Phase 3
• A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine HeadacheRecruitingNCT06473597Phase 4
• Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric SubjectsRecruitingNCT05156398Phase 3
• Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of MigraineRecruitingNCT04743141Phase 3
• Randomized Study in Children and Adolescents With Migraine: Acute TreatmentRecruitingNCT04649242Phase 3
• Comparison of Rimegepant and Placebo for Pain in IBSCompletedNCT06221111Phase 2Results posted
• A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.CompletedNCT05810038Phase 3Results posted
• Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive MedicationsCompletedNCT05518123Phase 4Results posted
• Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan UseCompletedNCT05509400Phase 4Results posted
• Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only)CompletedNCT05399485Phase 3Results posted
• Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)CompletedNCT05399459Phase 3Results posted
• A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese ParticipantsCompletedNCT05371652Phase 3Results posted
• Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular DisordersTerminatedNCT05262517Phase 3Results posted
• Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic RhinosinusitisCompletedNCT05248997Phase 3Results posted
• Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing RegimensCompletedNCT05217927Phase 4Results posted
• Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine PreventionCompletedNCT05207865Phase 4Results posted
• An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute HeadacheCompletedNCT04860713Phase 4Results posted
• Rimegepant in Moderate Plaque-type PsoriasisCompletedNCT04629950Phase 2Results posted
• Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of MigraineCompletedNCT04574362Phase 3Results posted
• Trial for Treatment Refractory Trigeminal NeuralgiaTerminatedNCT03941834Phase 2Results posted
• Efficacy and Safety Trial of Rimegepant for Migraine Prevention in AdultsCompletedNCT03732638Phase 2/3Results posted
• Trial in Adult Subjects With Acute MigrainesCompletedNCT03461757Phase 3Results posted
• Open Label Safety Study in Acute Treatment of MigraineCompletedNCT03266588Phase 2/3Results posted
• Safety and Efficacy in Adult Subjects With Acute MigrainesCompletedNCT03237845Phase 3Results posted
• Safety and Efficacy Study in Adult Subjects With Acute MigrainesCompletedNCT03235479Phase 3Results posted
• Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of MigraineCompletedNCT01430442Phase 2Results posted
• The R-E-V-I-V-A-L StudyActive, not recruitingNCT06992674Phase 2
• Acute Migraine Treatment in the ED With GepantsTerminatedNCT06985342Phase 4
• A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent MigraineActive, not recruitingNCT06616194Phase 3
• Cluster Headache Treatment With RimegepantCompletedNCT05264714Phase 2
• Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine ConditionCompletedNCT01445067Phase 1

← Rimegepant overview